Pharvaris (PHVS) Change in Cash (2020 - 2026)
Pharvaris' (PHVS) quarterly Change in Cash came in at -$57.2 million in Q1 2026, down 40.55% YoY from -$96.3 million in Q1 2025, and down 30.46% on a QoQ basis from -$43.9 million in Q4 2025.
Analysis
Pharvaris (PHVS) Change in Cash (2020 - 2026) Analysis & Trends
Pharvaris (PHVS) has 7 years of Change in Cash data on file, last reported at -$57.2 million in Q1 2026.
- Quarterly Change in Cash fell 40.55% year-over-year to -$57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 111.65% YoY) and the FY2025 annual result came in at $26.4 million, up 120.67% from the prior year.
- Change in Cash retreated to -$57.2 million in Q1 2026, from -$43.9 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $19647.1 billion in Q2 2023 to a low of -$19641.1 billion in Q3 2023.
- A 5-year average of $356.6 million and a median of -$27.1 million in 2023 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 385414451.59% in 2023, down 127777546.09% in 2023.
- Tracing PHVS's Change in Cash over 5 years: stood at -$21.0 million in 2022, then surged by 1318.07% to $256.0 million in 2023, then sank by 114.42% to -$36.9 million in 2024, then dropped by 18.81% to -$43.9 million in 2025, then tumbled by 30.46% to -$57.2 million in 2026.
- The last three Change in Cash figures came in at -$57.2 million (Q1 2026), -$43.9 million (Q4 2025), and $151.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Pharvaris | 2.10 Bn | 1.73 Bn | 85,072.10 | 79.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.09 Mn |
| Mar 31, 2026 | -57.23 Mn |
| Dec 31, 2025 | -43.86 Mn |
| Sep 30, 2025 | 151.68 Mn |
| Jun 30, 2025 | -33.94 Mn |
| Mar 31, 2025 | -40.72 Mn |
| Dec 31, 2024 | -36.92 Mn |
| Sep 30, 2024 | 55,863.43 Bn |
| Jun 30, 2024 | -54,778.40 Bn |
| Mar 31, 2024 | -25.49 Mn |
| Dec 31, 2023 | 255.96 Mn |
| Sep 30, 2023 | -19,641.07 Bn |
| Jun 30, 2023 | 19,647.11 Bn |
| Mar 31, 2023 | -27.13 Mn |
| Dec 31, 2022 | -21.01 Mn |
| Sep 30, 2022 | 22,983.57 Bn |
| Jun 30, 2022 | -24,323.54 Bn |
| Mar 31, 2022 | -20.22 Mn |
| Dec 31, 2021 | -15.09 Mn |
| Sep 30, 2021 | -11.89 Mn |